News & Events
March 16 (St. Paul, MN) - Dr. Whitelaw will attend and speak at Mitchell Hamline's Health Law Institute Symposium. This year's program is entitled Hot Topics In Healthcare Compliance.
March 22 (Philadelphia, PA) - Dr. Whitelaw will attend and speak at the CBI's 2nd Annual Drug Pricing Transparency Conference.
April 23-25 (Washington, DC) - WCG will attend CBI's Pharmaceutical Compliance Congress 2018.
Practical Compliance for Innovative Companies
Healthcare innovation is no longer the domain of large companies. Today innovation is driven by smaller, highly focused, and in many cases virtual, pharmaceutical and medical device companies. Companies focused on one or two niche areas. Compliance Officers and Departments are essential to managing legal and compliance risks. Without them, smaller companies with breakthrough products stand little chance of navigating this highly-regulated industry. Without these companies, healthcare will not advance.
At Whitelaw Compliance Group, we focus on small to medium-sized pharmaceutical and medical device companies. We believe that from humble acorns mighty oaks will grow. We believe that every company needs access to high quality, practical compliance; compliance that fits the company and does not waste time or money.
We specialize in taking a blank sheet of paper and creating practical compliance programs for our clients - custom-tailored programs that are affordable, efficient, effective. We can do this because we've built them and run them and done them for life science clients of all ages and sizes.
To learn more about how we can help you, please dial +1-215-275-1556.
- MISSING THE MARKET: GOVERNMENT STANDARDS ARE UNDERMINING COMPLIANCE EFFORTS IN SMALLER LIFE SCIENCE COMPANIES
- A Bright Future or Unfulfilled Promise – An Update on Biosimilars and Their Prospects for Contributing to Meaningful Cost Reduction
- One Purpose to Rule Them All – A Resounding “Yes “According to the District Court in U.S. ex rel. Cairns
Papers & Presentations
Whitelaw, Seth, and Fiorentino, Nicodemo and O'Leary, Jennifer, Drug Pricing - The Next Compliance Waterloo (February 21, 2018). 44 Mitchell Hamline L. Rev. (2018 Forthcoming). Available at SSRN: https://ssrn.com/abstract=3127733
PRESENTATION: Industry at a Crossroads: Legal and Ethical Considerations of Selling Pharmaceuticals in 2016 given at Mitchell Hamline's Health Law Institute
New Approaches: Focused Monitoring for Smaller Companies